Araştırma
Eğitim
Çözümler
Oturum Aç
TR
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
TR - Turkish
JA - Japanese
Institute of Bioengineering and Swiss Institute of Experimental Cancer Research (ISREC)
Manuel Fankhauser has not added Biography.
If you are Manuel Fankhauser and would like to personalize this page please email our Author Liaison for assistance.
TIL therapy broadens the tumor-reactive CD8(+) T cell compartment in melanoma patients.
Oncoimmunology Jul, 2012 | Pubmed ID: 22754759
A catalytically inactive mutant of the deubiquitylase YOD-1 enhances antigen cross-presentation.
Blood Feb, 2013 | Pubmed ID: 23243279
École Polytechnique Fédérale de Lausanne
Esra Güç*,1,
Manuel Fankhauser*,1,
Amanda W. Lund1,2,
Melody A. Swartz1,
Witold W. Kilarski1
1Institute of Bioengineering and Swiss Institute of Experimental Cancer Research (ISREC), École Polytechnique Fédérale de Lausanne,
2Department of Cell and Developmental Biology and Knight Cancer Institute, Oregon Health & Science University
Gizlilik
Kullanım Şartları
İlkeler
Bize Ulaşın
KÜTÜPHANEYE TAVSİYE ET
JoVE HABER BÜLTENLERİ
JoVE Journal
Yöntem Koleksiyonları
JoVE Encyclopedia of Experiments
Arşiv
JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
Fakülte Kaynak Merkezi
Yazarlar
Kütüphaneciler
Erişim
JoVE Hakkında
Telif Hakkı © 2020 MyJove Corporation. Tüm hakları saklıdır